Abstract Details

Title Adult Chediak-Higashi Syndrome Presenting as Spastic Paraplegia, Cerebellar Ataxia and Neuropathy

Topic Neurotoxicology

Presentation(s) P06 - (-)

Poster/Presentation
Number 221

Objective

Background BACKGROUND: Autosomal recessive hereditary spastic paraplegias (AR-HSP) constitute a heterogeneous group of neurodegenerative diseases involving pyramidal tracts dysfunction. The genes responsible for many types of AR-HSPs remain unknown. We attempted to identify the gene responsible for autosomal recessive hereditary spastic paraplegia with cerebellar ataxia and neuropathy.

Design/Methods DESIGN/METHODS: The present study included two patients in a Japanese consanguineous family. Their onset of symptoms was 48 and 58 years of age. Neurologic examination and DNA analysis were underwent in two patients and two normal family members. We performed a genomewide linkage analysis employing SNP arrays with two patients' DNAs and exome sequencing using one patient's sample.

Results RESULTS: We identified a homozygous missense mutation in the lysosomal trafficking regulator (LYST) gene in the two patients. This mutation co-segregated with the disease in the family, and located at the well-conserved amino acid. This LYST mutation was not found in 200 Japanese control DNAs. Subsequent hematological analysis in one patient could disclose peroxidase-positive large granules in the patient's granulocytes, although he had no symptoms according to immunodeficiency or bleeding tendency.

Conclusions CONCLUSIONS: We considered these patients as adult Chediak-Higashi syndrome (CHS) presenting spastic paraplegia with cerebellar ataxia and neuropathy. As far as we know, this family is one of the oldest adult CHS cases in the literatures. Clinical spectrum of CHS is broader than previously recognized. Adult CHS must be considered in the differential diagnosis of AR-HSPs. The linkage analysis and exome sequencing were useful for identifying the causative mutation in this family.

Authors/Disclosures
Haruo Shimazaki, MD, PhD (Saitama Medical University) PRESENTER	No disclosure on file
	No disclosure on file
Hiroyuki Ishiura, MD (The University of Tokyo)	No disclosure on file
Shoji Tsuji, MD, PhD (University of Tokyo)	The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
	No disclosure on file
Imaharu Nakano, MD (Jichi Medical University)	No disclosure on file
Joerg Windsheimer, MD	No disclosure on file

��ɫ��

��ɫ��